Cargando…

QOL-31. USE OF PATIENT-REPORTED OUTCOMES TO IDENTIFY YOUTH AT RISK FOR IMPAIRED OVERALL HEALTH

Pediatric brain tumor survivors often experience persistent and clinically significant late-effects following treatment. Critical to understanding morbidity is utilization of patient-reported outcomes (PROs). The current study evaluated PROs of individuals previously diagnosed with a pediatric brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingerski, Lisa, Lewis, Rebecca Williamson, Mertens, Ann, MacDonald, Tobey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuropsychology/Quality of Life
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715909/ http://dx.doi.org/10.1093/neuonc/noaa222.691

Ejemplares similares

QOL-31. A psychosocial support program for young adult childhood cancer survivors in Austria: a qualitative evaluation study
por: Pletschko, Thomas, et al.
Publicado: (2022)

QOL-49. THE IMPACT OF OTOTOXICITY AND VISUAL IMPAIRMENT ON EDUCATION IN CHILDREN TREATED FOR CNS TUMOURS
por: Dulson, Harriet, et al.
Publicado: (2020)

QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-06. QUALITY OF LIFE IN MEDULLOBLASTOMA SURVIVORS IN WESTERN MEXICO
por: del Campo, Regina M Navarro-Martin, et al.
Publicado: (2020)

QOL-27. SWALLOWING ASSESSMENT IN PEDIATRIC PATIENTS WITH BRAIN TUMOR
por: Machado, Natalia Oliveira, et al.
Publicado: (2020)

QOL-43. ENDOCRINE AND METABOLIC CHANGES IN CHILDREN TREATED FOR MEDULLOBLASTOMA
por: Kalinin, Alexey, et al.
Publicado: (2020)

QOL-46. LATE EFFECTS CARE FOR CHILDHOOD BRAIN TUMOUR SURVIVORS: A QUALITY IMPROVEMENT PROJECT
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-09. WHOLE-BRAIN WHITE MATTER NETWORK CONNECTIVITY IS DISRUPTED BY PEDIATRIC BRAIN TUMOR TREATMENT
por: Oyefiade, Adeoye, et al.
Publicado: (2020)

QOL-48. INTERDISCIPLINARY SPIRITUAL CARE TRAINING IN PEDIATRIC NEURO-ONCOLOGY
por: Lion, Alex, et al.
Publicado: (2020)

QOL-58. ASSESSING FATIGUE EXPERIENCED BY PEDIATRIC PATIENTS WITH INTRACRANIAL NEOPLASMS
por: Eccles, Eamon, et al.
Publicado: (2020)

QOL-41. CARDIAC DYSFUNCTION IN MEDULLOBLASTOMA SURVIVORS TREATED WITH PHOTON IRRADIATION
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-40. THE IMPACT OF TASK COMPLEXITY ON INFORMATION PROCESSING SPEED AND NEURAL COMMUNICATION IN PAEDIATRIC BRAIN TUMOUR SURVIVORS
por: Cox, Elizabeth, et al.
Publicado: (2020)

QOL-15. NEURAL NETWORK INTEGRITY FOR FACIAL AFFECT RECOGNITION IN SURVIVORS OF MEDULLOBLASTOMA
por: Brinkman, Tara, et al.
Publicado: (2020)

QOL-05. TUMOR LOCATION IS LESS LIKELY INFLUENCE ON COGNITIVE DYSFUNCTION IN CHILDREN
por: Nakajima, Riho, et al.
Publicado: (2020)

QOL-36. USE OF CANNABINOIDS IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR POPULATION
por: Dorris, Kathleen, et al.
Publicado: (2020)

QOL-28. NEUROCOGNITIVE PROFILE OF PEDIATRIC MEDULLOBLASTOMA PATIENTS PRIOR TO RADIATION THERAPY
por: Baig, Muhammad, et al.
Publicado: (2020)

QOL-56. THE RELAPSED AND OR PROGRESSED BRAIN TUMOURS IN CHILDREN: RHC, GLASGOW EXPERIENCE
por: Sastry, Jairam, et al.
Publicado: (2020)

QOL-54. HEIGHT, WEIGHT AND CARDIOVASCULAR EFFECTS OF STIMULANTS ON CHILDREN WITH BRAIN TUMOR
por: Khan, Raja, et al.
Publicado: (2020)

QOL-07. The importance of an onco-fertility program for pediatric neuro-oncology patients
por: IJgosse, Irene, et al.
Publicado: (2022)

QOL-01. Inflammatory biomarkers and psychological sequela in pediatric brain tumor survivors
por: Turner, Emily, et al.
Publicado: (2022)

QOL-29. Neuropsychology for you“ – tools to improve awareness of and access to neuropsychological care
por: Weiler-Wichtl, Liesa Josephine, et al.
Publicado: (2022)

QOL-23. ASSESSING THE IMPACT OF METHYLPHENIDATE ON LATE COGNITIVE EFFECTS IN PAEDIATRIC BRAIN TUMOUR SURVIVORS: A SERVICE-BASED EVALUATION
por: Verity, Sarah, et al.
Publicado: (2020)

QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY
por: Kahalley, Lisa, et al.
Publicado: (2020)

QOL-07. CORTICAL VOLUME AND THICKNESS IN ADULT SURVIVORS OF CHILDHOOD POSTERIOR FOSSA TUMORS
por: Sleurs, Charlotte, et al.
Publicado: (2020)

QOL-57. SOUTHERN CALIFORNIA KAISER PERMANENTE PEDIATRIC NEURO-ONCOLOGY PROGRAM DEVELOPMENT
por: Tran, Hung
Publicado: (2020)

QOL-18. A LONGITUDINAL STUDY OF NEUROCOGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR
por: Lemiere, Jurgen, et al.
Publicado: (2020)

QOL-55. INTEGRATED MULTI-SCALE MODEL FOR PEDIATRIC BRAIN TUMOR SURVIVAL PREDICTION
por: Qiu, Yeping Lina, et al.
Publicado: (2020)

QOL-03. Beyond Survival: Clinical Rehabilitation and Functional Optimization Pearls for the Neuro-Oncologist
por: Rosenberg, Nathan
Publicado: (2022)

QOL-11. Comparison of Neuropsychological Functioning in Pediatric Posterior Fossa Tumor Survivors: Medulloblastoma, Low-Grade Astrocytoma, and Healthy Controls
por: Levitch, Cara, et al.
Publicado: (2022)

QOL-22. MACHINE-LEARNING INFERENCE MAY PREDICT QUALITY OF LIFE SUBGROUPS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Hengartner, Astrid C, et al.
Publicado: (2020)

QOL-21. DEVELOPMENT AND UTILISATION OF A NEURO-ONCOLOGY REHABILITATION TEAM: 2018–2019 UPDATE
por: Paisley, Helen, et al.
Publicado: (2020)

QOL-12. CLINICAL SIGNIFICANCE OF RADIATION-INDUCED CEREBROVASULAR DISEASE IN CHILDHOOD BRAIN TUMOR SURVIVORS
por: Remes, Tiina, et al.
Publicado: (2020)

QOL-09. SyMon-SAYS: A symptom monitoring and reporting program for children with cancer
por: Lai, Jin-Shei, et al.
Publicado: (2022)

QOL-26. I’VE GOT FRIENDS NOW: PAEDIATRIC PATIENTS’ EXPERIENCES OF METHYLPHENIDATE TREATMENT FOR NEUROCOGNITIVE LATE-EFFECTS ASSOCIATED WITH BRAIN TUMOUR
por: Verity, Sarah, et al.
Publicado: (2020)

QOL-34. CAREER FAIR AND RESOURCE EXPO: ADVOCATING FOR THE LONG TERM SUCCESS OF BRAIN TUMOR SURVIVORS
por: Hoerig, Clay, et al.
Publicado: (2020)

QOL-38. USE OF COMPUTERIZED NEUROPSYCHOLOGICAL MEASURES TO ASSESS COGNITIVE MORBIDITY IN SURVIVORS OF CHILDHOOD BRAIN TUMORS
por: Dickson, Duncan, et al.
Publicado: (2020)

QOL-32. Patients treated for malignant brain tumor in the first three years of life: clinical sequelae
por: Giaquinta, Simonetta, et al.
Publicado: (2022)

QOL-17. Neurocognitive outcomes after treatment for medulloblastoma with reduced primary site target volume margins
por: Larkin, Trisha, et al.
Publicado: (2022)

QOL-33. Adaptive behaviour of patients treated for malignant brain tumor in the first three years of life
por: Giaquinta, Simonetta, et al.
Publicado: (2022)

QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
por: Bullens, Kristien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_daadbgeegke8q52c9m8s0vj35n